bendekahcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * Disallow: Sitemap: | ||
Meta Tags
| Title | BENDEKA® (bendamustine HCl) |
| Description | Learn more about BENDEKA® (bendamustine HCl) |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.60.151.76 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
bendekahcp.com Valuation
|
US$2,085,812
Last updated: 2023-05-08 15:12:41
bendekahcp.com has Semrush global rank of 5,074,429. bendekahcp.com has an estimated worth of US$ 2,085,812, based on its estimated Ads revenue. bendekahcp.com receives approximately 240,671 unique visitors each day. Its web server is located in United States, with IP address 45.60.151.76. According to SiteAdvisor, bendekahcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,085,812 |
| Daily Ads Revenue | US$1,926 |
| Monthly Ads Revenue | US$57,761 |
| Yearly Ads Revenue | US$693,132 |
| Daily Unique Visitors | 16,045 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| bendekahcp.com. | A | 7199 | IP: 45.60.151.76 |
| bendekahcp.com. | A | 7199 | IP: 45.60.171.76 |
| bendekahcp.com. | NS | 86400 | NS Record: ns5.tevapharm.com. |
| bendekahcp.com. | NS | 86400 | NS Record: ns3.tevapharm.com. |
| bendekahcp.com. | NS | 86400 | NS Record: ns4.tevapharm.com. |
| bendekahcp.com. | TXT | 86400 | TXT Record: v=spf1 ~all |
| bendekahcp.com. | TXT | 86400 | TXT Record: _globalsign-domain-verification=-mrCDIV71wAl5ZEI_KNjAQkTP909CIi-uVPaygQrSE |
HtmlToTextCheckTime:2023-05-08 15:12:41
| CLL Efficacy data Safety Dosing and administration iNHL Efficacy data Safety Dosing and administration Dosing and Administration Dosing and treatment costs Administration Patient Access Legal Notice Contact Us For Patients Prescribing Information Important Safety Information CLL Efficacy data Safety Dosing and administration iNHL Efficacy data Safety Dosing and administration Dosing and Administration Dosing and treatment costs Administration Patient Access BENDEKA is indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) — efficacy relative to first-line therapies other than chlorambucil has not been established — or patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Offer your patients a short, fixed course of therapy with BENDEKA 1 Patients have time off treatment after infusing 1 : CLL iNHL On Day 1 and Day 2 at 100 mg/m 2 administered |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: https://www.bendekahcp.com/ Content-Length: 0 Connection: close HTTP/2 200 cache-control: no-cache pragma: no-cache content-length: 37733 content-type: text/html; charset=utf-8 expires: -1 server: Microsoft-IIS/10.0 set-cookie: ASP.NET_SessionId=0tdc0chffz3qx405vidxbq0r; path=/; HttpOnly; SameSite=Lax x-aspnetmvc-version: 5.2 x-aspnet-version: 4.0.30319 x-powered-by: ASP.NET arr-disable-session-affinity: true x-frame-options: DENY date: Sat, 30 Oct 2021 06:37:06 GMT set-cookie: visid_incap_1938340=Hw8pMeuFQDu7tMklpw7cjxLofGEAAAAAQUIPAAAAAAAckZEHoVtk+qjSnAEJJKmj; expires=Sat, 29 Oct 2022 11:20:52 GMT; HttpOnly; path=/; Domain=.bendekahcp.com set-cookie: nlbi_1938340=cdNiKQyYRm3TetLRvZyZxQAAAAANlXSlxTsYko3slIoC/ub2; path=/; Domain=.bendekahcp.com set-cookie: incap_ses_8222_1938340=LKoOQG/mXE4wUNRtlWkachLofGEAAAAAnaO8K6WyIYAs0Jv7U9Vg+w==; path=/; Domain=.bendekahcp.com x-cdn: Imperva x-iinfo: 14-189032721-189032722 NNNN CT(24 51 0) RT(1635575826496 0) q(0 0 1 0) r(3 3) U6 |
bendekahcp.com Whois Information
Domain Name: BENDEKAHCP.COM Registry Domain ID: 1943273824_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.comlaude.com Registrar URL: http://www.comlaude.com Updated Date: 2021-06-24T23:11:17Z Creation Date: 2015-06-29T19:05:35Z Registry Expiry Date: 2022-06-29T19:05:35Z Registrar: Nom-iq Ltd. dba COM LAUDE Registrar IANA ID: 470 Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +442074218250 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS3.TEVAPHARM.COM Name Server: NS4.TEVAPHARM.COM Name Server: NS5.TEVAPHARM.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T17:24:31Z <<< |